MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study

    A. Roux, F. Durif, A. Marques, J. Bonny, B. Pereira (Clermont Ferrand, France)

    Objective: To study morphometric and structural connectivity changes in the mesocorticolimbic pathway associated with the occurrence of impulse control disorders in Parkinson's disease. Background: Impulse…
  • MDS Virtual Congress 2020

    Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach

    A. Bhattacharya, N. Kamble, A. S, V. N, A. Stezin, S. Hegde, A. J, R. Yadav, P. Pal (Bengaluru, India)

    Objective: This paper aims at creating a computer-based diagnosis tool which can predict the classification of MCI and dementia in patients of Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Impulse Control Behaviours in People with Parkinson’s Disease: Findings from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

    A. Antonini, E. Tolosa, J. Ferreira, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Padova, Italy)

    Objective: Presence of impulse control behaviour (ICB) was assessed in PRISM, a European survey of people with Parkinson’s disease (PwP) and their care-partners. Background: Impulse…
  • MDS Virtual Congress 2020

    Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease

    I. Lin, B. Edison, S. Mantri, M. Daeschler, K. Kopil, C. Marras, L. Chahine (Pittsburgh, PA, USA)

    Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…
  • MDS Virtual Congress 2020

    Sleep Patterns in Relation to Disease Severity in Parkinson’s Disease: A Study of 84 Ibadan Patients

    R. Oguntoye (Ibadan, Nigeria)

    Objective: To assess the sleep patterns in relation to disease severity. Background: Parkinson’s disease is a progressive neurodegenerative disease. The non-motor symptoms are said to…
  • MDS Virtual Congress 2020

    Association Between Fatigue, Depression and Sleep Disorders in People with Parkinson’s Disease

    G. Xavier-Souza, I. Alves, A. Mendoza, L. Almeida, G. Valença (Salvador, Brazil)

    Objective: To identify the association between fatigue, sleep disorders and depression in people with Parkinson’s disease (PD). Background: Fatigue is one of the most prevalent…
  • MDS Virtual Congress 2020

    Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus

    H. Bejr-kasem, J. Pagonabarraga, F. Sampedro, S. Martínez-Horta, R. Perez-Gonzalez, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, A. Campolongo, C. Izquierdo, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…
  • MDS Virtual Congress 2020

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study

    B. Bergmans, V. Schotte, N. Sys, E. Van Massenhove, M. Van Zandijcke (Brugge, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles into the…
  • MDS Virtual Congress 2020

    Quantifying movement to measure Parkinson’s Disease severity and progression in a Phase 2 Study (SPARK)

    K.P Kilambi, S. Khan, J. Osik, T. Herrero, J. Edgerton, K. Erb, K. Hallock, M. Brys, M. Yang, J. Xiao, I. Sapir, T. Fox, P. Bergethon (Cambridge, MA, USA)

    Objective: To develop and evaluate objective measures of Parkinson’s disease (PD) severity and progression by applying dynamical systems analysis to inertial sensor kinematic data. Background:…
  • MDS Virtual Congress 2020

    Effects of Nabilone on non-motor symptoms of Parkinson´s Disease: A randomised placebo-controlled study (The NMS-Nab Study)

    M. Peball, F. Krismer, H.G Knaus, A. Djamshidian, M. Werkmann, F. Carbone, P. Ellmerer, B. Heim, K. Marini, D. Valent, G. Goebel, H. Ulmer, H. Stockner, G.K Wenning, R. Stolz, K. Krejcy, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To investigate the effects of the synthetic cannabinoid nabilone for the treatment of non-motor symptoms in Parkinson´s disease (PD) in a controlled fashion. Background:…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley